Abstract 4216: Advancing cancer immunotherapy through the development of a novel selective HDAC6 inhibitors
Year: 2025
Type: conference-abstract
Source: Cancer Research
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4409627640
